Ocular Therapeutix
Price & Volume
Stats
See more52W Range | $3.75-$11.77 |
Market Cap | $1.3B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $61M |
Revenue Growth (YoY) | 8.3% |
Gross Profit (12 Mos) | -$6.5M |
Diluted EPS | -$1.29 |
News
See moreYahoo Finance • last year
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
Yahoo Finance • last year
Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences
Yahoo Finance • last year
Ocular Therapeutix™ Provides Third Quarter 2023 Financial Results and Corporate Update
About
CEO | Dr. Pravin U. Dugel M.D. |
CFO | Mr. Donald Notman Jr. |
Address | 15 Crosby Drive, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 267 |
